Background The long-term trajectories of estimated glomerular filtration rate (eGFR) and their relation to early proteinuria ...
With an expiration date still more than a year away, here's what the latest details reveal.
These 4 big technology bets will reshape the global economy in 2026 ...
Here's how your social life could affect your dementia risk.
Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
Corewell Health has big plans for its Butterworth Hospital campus in Grand Rapids.
Full-Year 2025 Volumes -- Gas processing averaged 445 million cubic feet per day, crude terminaling averaged 129,000 barrels ...
In a multicenter, phase 2 trial across 31 centers in 10 countries, apecotrep (BI 764198) reduced proteinuria by 40% over 12 ...
Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with prima ...
Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...
SoftwareOne, WWT, Long View, Blue Mantis, DXC, Presidio, ePlus, EPAM, Optiv, Bluum and other solution provider CEOs share ...
National Bank Financial analysts Dan Payne and Travis Wood continues to see Canada’s energy sector as “a stock-pickers market” in 2026, pointing to upside in crude prices. “2025 was a tale of two ...